Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Advanced Chemotherapy Technologies is a startup developing a device that can infuse chemotherapies into poorly vascularized tumors.
KinaRx is a biotech firm focuses on the development of novel kinase inhibitors for the treatment of Acute myeloid leukemia.
Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases.
Advocate Aurora Health is a Healthcare
Clinical Decision Support for Pediatric Radiology
Lariat Biosciences is an employee-owned biotechnology start-up.
National Cancer Institute has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Cancer Institute's top investment sectors include Health Care, Medical, Biotechnology, Therapeutics, Artificial Intelligence (AI). The firm invests across 6 different industry categories.
Among tracked funding rounds, Advocate Aurora Health received $10.2M in a Grant round. National Cancer Institute's total known invested capital is $325.9M.
National Cancer Institute's average investment size is $3.4M across its portfolio of 102 companies.
Recent National Cancer Institute portfolio additions include Advanced Chemotherapy Technologies, KinaRx, Agilvax. These companies were founded in 2020 or later.